ROG.SW
$322.30
Roche Holding AG engages in the pharmaceuticals and diagnostics businesses in Europe, North America, Latin America, Asia, Africa, Australia, and New Zealand.
Historical Price
Peer Comparison
Whystock Valuation Model
Fundamentals
Roche Holding AG engages in the pharmaceuticals and diagnostics businesses in Europe, North America, Latin America, Asia, Africa, Australia, and New Zealand. The company offers pharma solutions in the therapeutic areas of anaemia, blood and solid tum...
Recent News
SRPT Stock Up as Enrollment Begins in DMD Gene Therapy Safety Study
Sarepta gains as enrollment begins in a new ENDEAVOR study cohort testing a sirolimus regimen to improve Elevidys safety in DMD patients.
Will Anktiva Continue to Drive ImmunityBio's Top-Line Growth in 2026?
IBRX's Anktiva fueled a 700% revenue surge in 2025, but can repeat prescriptions, global expansion and BCG shortages sustain momentum into 2026?
Trending tickers: Nvidia, Roche, Travis Perkins, Wickes and Close Brothers
The latest investor updates on stocks that are trending on Tuesday.
Assessing Roche (SWX:ROG) Valuation After Recent Share Price Volatility And Obesity Drug Pipeline Update
Roche Holding: Recent Moves and What They Mean for Investors Roche Holding (SWX:ROG) has been on investors’ radar after recent share price swings, with the stock showing mixed returns over the past week, month, and past 3 months. See our latest analysis for Roche Holding. At around CHF322.3 per share, Roche Holding’s recent 1-month share price return of a 10.47% decline contrasts with a positive 1-year total shareholder return of 10.30%. This suggests shorter term momentum has cooled while...
Roche ramps up AI computing capacity with Nvidia chip expansion
BERLIN, March 16 (Reuters) - Swiss drugmaker Roche said on Monday it had expanded its artificial intelligence computing capacity with more than 2,100 Nvidia chips to support drug and diagnostics